Ligand Receives $4 Million from Expansion of Two OmniAb® License Agreements
Go back to Ligand Receives $4 Million from Expansion of Two OmniAb® License Agreements| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 285.31 -3.94 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $289.25 | 52 Week High | $139.79 | |||
| Open | $291.48 | 52 Week Low | $82.07 | |||
| Day High | $294.00 | P/E | 663.51 | |||
| Day Low | $283.77 | EPS | $0.43 | |||
| Volume | 110,620 | |||||
